BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/13/2022 10:36:57 AM | Browse: 490 | Download: 1071
 |
Received |
|
2021-05-31 14:03 |
|
Peer-Review Started |
|
2021-05-31 14:08 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-07-03 14:00 |
|
Revised |
|
2021-07-18 02:04 |
|
Second Decision |
|
2022-04-27 02:38 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-04-28 02:25 |
|
Articles in Press |
|
2022-04-28 02:25 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-04-04 08:52 |
|
Typeset the Manuscript |
|
2022-04-30 00:16 |
|
Publish the Manuscript Online |
|
2022-05-13 10:36 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Pharmacology & Pharmacy |
| Manuscript Type |
Frontier |
| Article Title |
Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mona F El-Azab, Ahmed E Wakiel, Yossef K Nafea and Mahmoud E Youssef |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mona F El-Azab, PhD, Professor, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Suez Canal University, Kilo 4.5 Ring Road, Ismailia 41522, Egypt. mona_elazab@pharm.suez.edu.eg |
| Key Words |
Δ9-tetrahydrocannabinol; Autophagy; Cannabinoid receptors; Diabetic cardiomyopathy; Endocannabinoid system; Inflammation |
| Core Tip |
Diabetic cardiomyopathy is considered among the most common deleterious diabetic complications being the leading cause of mortality among diabetic patients. The endocannabinoid system has been implicated in the pathogenesis of diabetes and its complications. Yet, the role of the endocannabinoid system in diabetic cardiomyopathy has not been fully investigated. This review aims to elucidate the possible mechanisms through which cannabinoids and the endocannabinoid system could interact with the pathogenesis of diabetic cardiomyopathy. Better understanding of the role of cannabinoids and the endocannabinoid system in diabetic cardiomyopathy may provide novel strategies to manipulate such a serious diabetic complication. |
| Publish Date |
2022-05-13 10:36 |
| Citation |
El-Azab MF, Wakiel AE, Nafea YK, Youssef ME. Role of cannabinoids and the endocannabinoid system in modulation of diabetic cardiomyopathy. World J Diabetes 2022; 13(5): 387-407 |
| URL |
https://www.wjgnet.com/1948-9358/full/v13/i5/387.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v13.i5.387 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
